Article
C-kit+VEGFR-2+ Mesenchymal Stem Cells Differentiate into Cardiovascular Cells and Repair Infarcted Myocardium after Transplantation
2022-01-11
Abstract excerpt
<title>Abstract</title> <p><bold>Background: </bold>Resent preclinical studies and clinical trails prove that transplantation of mesenchymal stem cells (MSCs) is a promised therapy for ischemic diseases. However, the properties of c-kit<sup>+</sup> cells in MSCs remain unclear. We investigated<bold> </bold>the differential potential of c-kit<sup>+</sup>VEGFR-2<sup>+</sup> MSCs and evaluated their effects on repai...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f7c547f2-2aa0-5ff8-9080-bdf909d30634
- DOI
- 10.21203/rs.3.rs-1235054/v1
